Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,009 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bioavailability of marine n-3 fatty acid formulations.
Dyerberg J, Madsen P, Møller JM, Aardestrup I, Schmidt EB. Dyerberg J, et al. Prostaglandins Leukot Essent Fatty Acids. 2010 Sep;83(3):137-41. doi: 10.1016/j.plefa.2010.06.007. Prostaglandins Leukot Essent Fatty Acids. 2010. PMID: 20638827 Clinical Trial.
The acute effect of a single very high dose of N-3 fatty acids on coagulation and fibrinolysis.
Møller JM, Svaneborg N, Lervang HH, Varming K, Madsen P, Dyerberg J, Schmidt EB. Møller JM, et al. Thromb Res. 1992 Sep 1;67(5):569-77. doi: 10.1016/0049-3848(92)90017-5. Thromb Res. 1992. PMID: 1448789 Clinical Trial.
Forty healthy volunteers were randomized into two groups to receive either 20 grams of n-3 PUFA or 20 grams of n-6 PUFA as a single dose at 6 p.m. with their evening meal. ...
Forty healthy volunteers were randomized into two groups to receive either 20 grams of n-3 PUFA or 20 grams of n-6 PUFA as a single dose at …
No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans.
Schmidt EB, Varming K, Møller JM, Bülow Pedersen I, Madsen P, Dyerberg J. Schmidt EB, et al. Scand J Clin Lab Invest. 1996 Feb;56(1):87-92. doi: 10.1080/00365519609088592. Scand J Clin Lab Invest. 1996. PMID: 8850177 Clinical Trial.
Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals.
Mølvig J, Pociot F, Worsaae H, Wogensen LD, Baek L, Christensen P, Mandrup-Poulsen T, Andersen K, Madsen P, Dyerberg J, et al. Mølvig J, et al. Scand J Immunol. 1991 Oct;34(4):399-410. doi: 10.1111/j.1365-3083.1991.tb01563.x. Scand J Immunol. 1991. PMID: 1656517 Clinical Trial.
Influence of Naloxone on the cellular immune response to head-up tilt in humans.
Klokker M, Secher NH, Madsen P, Olesen HL, Matzen S, Knigge U, Warberg J, Pedersen BK. Klokker M, et al. Eur J Appl Physiol Occup Physiol. 1997;76(5):415-20. doi: 10.1007/s004210050270. Eur J Appl Physiol Occup Physiol. 1997. PMID: 9367281 Clinical Trial.
The PS appeared more rapidly with Naloxone compared to control [5.7 (SEM 1.1) vs 22.3 (SEM 5.1) min; P = 0.01]. The NK cell activity increased threefold during PS partly due to an increase in CD16+ and CD56+ NK cells in blood. ...
The PS appeared more rapidly with Naloxone compared to control [5.7 (SEM 1.1) vs 22.3 (SEM 5.1) min; P = 0.01]. The NK cell activity …
Subcutaneous oxygen and carbon dioxide tensions during head-up tilt-induced central hypovolaemia in humans.
Larsen PN, Moesgaard F, Madsen P, Pedersen M, Secher NH. Larsen PN, et al. Scand J Clin Lab Invest. 1996 Feb;56(1):17-24. doi: 10.3109/00365519609088583. Scand J Clin Lab Invest. 1996. PMID: 8850168

Incremental tilting to 50 degrees increased heart rate (HR) and mean arterial pressure (MAP) (p < 0.01), while stroke volume (SV), cardiac output (CO) and central venous saturation (SvO2) decreased (p < 0.05). Presyncopal symptoms appeared after 28 (8-48) min

Incremental tilting to 50 degrees increased heart rate (HR) and mean arterial pressure (MAP) (p < 0.01), while stroke volume (SV),

Central venous oxygen saturation during hypovolaemic shock in humans.
Madsen P, Iversen H, Secher NH. Madsen P, et al. Scand J Clin Lab Invest. 1993 Feb;53(1):67-72. doi: 10.1080/00365519309092533. Scand J Clin Lab Invest. 1993. PMID: 8451602

Cardiac output decreased from 4.3 (3.0-4.8) to 2.7 (1.8-4.8) l min-1 (p < 0.03). After 29 (9-56) min presyncopal symptoms appeared, together with a decrease in MAP to 63 (43-79) mmHg, HR to 68 (30-112) beats min-1 and TPR to 22 (13-33) mmHg min l-1 (p < 0.02).

Cardiac output decreased from 4.3 (3.0-4.8) to 2.7 (1.8-4.8) l min-1 (p < 0.03). After 29 (9-56) min presyncopal symptoms appeared

1,009 results
Jump to page
Feedback